Breakthrough in Understanding Nicotine Production in Tobacco Plants

Tobacco has been a part of human culture for thousands of years, yet nicotine extraction from its leaves only began in the late 1820s. Fast forward to today, and scientists have made a significant discovery regarding how tobacco plants actually produce nicotine molecules.

This advancement could lead to major changes in how we use tobacco, especially in a field known as ‘plant molecular farming’. Over recent years, researchers have been engineering tobacco to create therapeutic compounds and even vaccines. However, nicotine poses a major challenge due to its addictive nature.

If scientists gain a better understanding of nicotine production, they might find ways to inhibit it in plants. “It’s a significant moment in plant science and biochemistry. We finally have the answer we’ve been pursuing for more than 200 years,” states Benjamin Lichman, a biologist from the University of York.

In their recent study, Lichman and his team from the University of Copenhagen pinpointed the genes and enzymes involved in nicotine synthesis. According to Lichman, “With this knowledge, we can either eliminate or repurpose the nicotine naturally produced by the plant, allowing for the creation of better biotechnology tools.” He also sees potential for adapting tobacco’s nicotine-producing system for pharmaceutical uses.

Through genetic analysis of tobacco (Nicotiana tabacum), researchers identified genes that are closely positioned in the plant’s DNA and activate concurrently with known nicotine-related genes. They isolated the enzymes tied to these genes and demonstrated in lab tests and live plants how these enzymes work together to form nicotine.

An interesting aspect of this mechanism involves glucose. Initially, a glucose molecule bonds with the building blocks of nicotine, facilitating the chemical reaction required for production. Once the process finalizes, the glucose molecule detaches, effectively vanishing after it has served its purpose.

The team found two specific enzymes, NaGR and NicGS, crucial for assembling the nicotine molecule from its fundamental components, which include an amino acid related to proteins and a vitamin-like substance. Lichman mentions, “It’s fascinating because it has real-world implications.” He also notes that a tobacco relative, Nicotiana benthamiana, is already employed in producing essential drugs and vaccines.

According to Lichman, this discovery opens new avenues for using tobacco plants in positive ways—much different from their traditional use in cigarettes. Another study further corroborates these findings, indicating that nicotine is indeed formed with the help of glucose and a series of enzymes, with the glucose disappearing after its role is fulfilled. This unique process is part of what made the nicotine production pathway so difficult to uncover.

While some questions remain about nicotine production in tobacco, researchers now have a clearer understanding of the main steps and vital ingredients. They suggest that the process could be modified to create tobacco with lower nicotine levels, though past attempts have sometimes stunted plant growth.

In essence, this research not only clarifies a mystery that’s been around for two centuries but also sets the stage for advancements in bioengineering. As Lichman notes, “Tobacco plants can serve as platforms for producing vaccines or other pharmaceuticals, but nicotine’s presence complicates matters since it contaminates the products.” The research findings are documented in the journal Nature Communications.